Progress in Pharmacotherapy for Obesity

Viewpoint from US perspective notes use of medications has been limited by perceived modest efficacy, safety concerns, patient and clinician reluctance, and lack of reimbursement. It discusses newer medications, including those with novel “twincretin” mechanisms of action.

Source:

Journal of the American Medical Association